Literature DB >> 26694650

Uptake and Toxicity of Hemin and Iron in Cultured Mouse Astrocytes.

Jessica E Owen1, Glenda M Bishop1, Stephen R Robinson2.   

Abstract

Hemin is a breakdown product of the blood protein, hemoglobin and is responsible for much of the secondary damage caused following a hemorrhagic stroke. Hemin is toxic to cultured astrocytes and it is thought that this toxicity is due to iron that is liberated when hemin is degraded. However, free iron applied to astrocytes is not toxic and the reason for this discrepancy is unknown. The present study exposed primary astrocyte cultures from neonatal mice to hemin-iron (25 µM hemin) or non-hemin iron (25 µM ferric ammonium citrate; FAC) for 12 or 24 h. Perls' and Turnbull's staining, as well as measures of cell viability and iron accumulation, were used to assess the valency, solubility and distribution of iron within cells. While cells accumulated similar amounts of iron from both sources, hemin was shown to be highly toxic to astrocytes, whereas FAC was not. Iron released by the degradation of hemin was present in both valencies (Fe(2+) and Fe(3+)), was mostly soluble and did not induce ferritin expression in most cells, whereas non-hemin iron (from FAC) was present in astrocytes almost exclusively as insoluble Fe(3+) and it induced widespread ferritin expression. These results show that the cellular mechanisms for processing hemin-iron and non-hemin iron are very different. The data suggest that hemin-iron has a greater potential to damage astrocytes by participating in unregulated redox reactions.

Entities:  

Keywords:  Astrocytes; Brain; Fenton chemistry; Ferritin; Heme oxygenase; Oxidative stress

Mesh:

Substances:

Year:  2015        PMID: 26694650     DOI: 10.1007/s11064-015-1795-7

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  28 in total

Review 1.  Labile iron pool: the main determinant of cellular response to oxidative stress.

Authors:  Marcin Kruszewski
Journal:  Mutat Res       Date:  2003-10-29       Impact factor: 2.433

2.  TNF alpha affects the expression of GFAP and S100B: implications for Alzheimer's disease.

Authors:  M M Edwards; S R Robinson
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

Review 3.  Iron: a pathological mediator of Alzheimer disease?

Authors:  Glenda M Bishop; Stephen R Robinson; Quan Liu; George Perry; Craig S Atwood; Mark A Smith
Journal:  Dev Neurosci       Date:  2002       Impact factor: 2.984

4.  The metabolism and toxicity of hemin in astrocytes.

Authors:  Theresa N Dang; Glenda M Bishop; Ralf Dringen; Stephen R Robinson
Journal:  Glia       Date:  2011-06-16       Impact factor: 7.452

5.  Hemoglobin potentiates the production of reactive oxygen species by alveolar macrophages.

Authors:  L J Huffman; P R Miles; X Shi; L Bowman
Journal:  Exp Lung Res       Date:  2000 Apr-May       Impact factor: 2.459

6.  Activation of extracellular signal-regulated kinases potentiates hemin toxicity in astrocyte cultures.

Authors:  R F Regan; Y Wang; X Ma; A Chong; Y Guo
Journal:  J Neurochem       Date:  2001-11       Impact factor: 5.372

Review 7.  Intracerebral haemorrhage.

Authors:  Adnan I Qureshi; A David Mendelow; Daniel F Hanley
Journal:  Lancet       Date:  2009-05-09       Impact factor: 79.321

8.  Mechanism of in vitro heme-induced LDL oxidation: effects of antioxidants.

Authors:  K Klouche; M Morena; B Canaud; B Descomps; J J Beraud; J P Cristol
Journal:  Eur J Clin Invest       Date:  2004-09       Impact factor: 4.686

9.  Uptake of ferrous iron by cultured rat astrocytes.

Authors:  Ketki Tulpule; Stephen R Robinson; Glenda M Bishop; Ralf Dringen
Journal:  J Neurosci Res       Date:  2010-02-15       Impact factor: 4.164

Review 10.  Heme degradation by reactive oxygen species.

Authors:  Enika Nagababu; Joseph M Rifkind
Journal:  Antioxid Redox Signal       Date:  2004-12       Impact factor: 8.401

View more
  8 in total

1.  Desferrioxamine Ameliorates Lipopolysaccharide-Induced Lipocalin-2 Upregulation via Autophagy Activation in Primary Astrocytes.

Authors:  Juntao Cui; Yu Yuan; Jun Wang; Ning Song; Junxia Xie
Journal:  Mol Neurobiol       Date:  2022-01-18       Impact factor: 5.590

2.  Hepcidin Protects Neuron from Hemin-Mediated Injury by Reducing Iron.

Authors:  Yu-Fu Zhou; Chao Zhang; Guang Yang; Zhong-Ming Qian; Meng-Wan Zhang; Juan Ma; Fa-Li Zhang; Ya Ke
Journal:  Front Physiol       Date:  2017-05-23       Impact factor: 4.566

3.  miR-331-3p Inhibits Inflammatory Response after Intracerebral Hemorrhage by Directly Targeting NLRP6.

Authors:  Hao Nie; Yang Hu; Wenliang Guo; Wenzhi Wang; Qingwu Yang; Qiang Dong; Yuping Tang; Qi Li; Zhouping Tang
Journal:  Biomed Res Int       Date:  2020-06-07       Impact factor: 3.411

4.  Increased expression of heme-binding protein 1 early in Alzheimer's disease is linked to neurotoxicity.

Authors:  Mahdokht Kohansal-Nodehi; Saravanan Gunaseelan; Oleksandr Yagensky; Tamara Rabe; Saima Zafar; Inga Zerr; Wolfgang Härtig; Henning Urlaub; John Je Chua
Journal:  Elife       Date:  2019-08-27       Impact factor: 8.140

Review 5.  Iron and Neurodevelopment in Preterm Infants: A Narrative Review.

Authors:  Kendell R German; Sandra E Juul
Journal:  Nutrients       Date:  2021-10-23       Impact factor: 5.717

6.  Ferroptosis in Intracerebral Hemorrhage: A Panoramic Perspective of the Metabolism, Mechanism and Theranostics.

Authors:  Chenxiao Lu; Changwu Tan; Hongfei Ouyang; Zhuohui Chen; Zhouyi Yan; Mengqi Zhang
Journal:  Aging Dis       Date:  2022-10-01       Impact factor: 9.968

7.  Protective effects of 1α,25-Dihydroxyvitamin D3 on cultured neural cells exposed to catalytic iron.

Authors:  Francesca Uberti; Vera Morsanuto; Claudio Bardelli; Claudio Molinari
Journal:  Physiol Rep       Date:  2016-06

8.  Iron Absorption from Three Commercially Available Supplements in Gastrointestinal Cell Lines.

Authors:  Francesca Uberti; Vera Morsanuto; Sabrina Ghirlanda; Claudio Molinari
Journal:  Nutrients       Date:  2017-09-13       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.